cyproteroneacetat/etinylestradiol alvogen (cypretyl) húðuð tafla 2/0,035 mg
alvogen ehf. - ethinylestradiolum inn; cyproteronum acetat - húðuð tafla - 2/0,035 mg
asubtela (ethinylestradiol/drospirenon 0,03 mg/3 mg focus) filmuhúðuð tafla 3 mg/ 0,03 mg
exeltis healthcare s.l. - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/ 0,03 mg
yasmin 28 filmuhúðuð tafla 0,03/3 mg
bayer ab - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 0,03/3 mg
yasmin filmuhúðuð tafla 0,03/3 mg
bayer ab - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 0,03/3 mg
cleodette filmuhúðuð tafla 3 mg/0,02 mg
teva b.v.* - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/0,02 mg
drovelis
gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - hormón kynlíf og stillum kynfæri - oral contraceptive.
lydisilka
estetra sprl - estetrol monohydrate, drospirenone - contraceptives, oral - hormón kynlíf og stillum kynfæri - getnaðarvörn til inntöku. the decision to prescribe lydisilka should take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (vte), and how the risk of vte with lydisilka compares with other combined hormonal contraceptives (chcs) (see sections 4. 3 and 4.
melleva filmuhúðuð tafla 0,15 mg/0,03 mg
exeltis healthcare s.l. - levonorgestrelum inn; ethinylestradiolum inn - filmuhúðuð tafla - 0,15 mg/0,03 mg
mercilon tafla 150 míkróg/20 míkróg
n.v. organon* - desogestrelum inn; ethinylestradiolum inn - tafla - 150 míkróg/20 míkróg
microgyn tafla
bayer ab* - levonorgestrelum inn; ethinylestradiolum inn - tafla